Full history for every metric is available with a Kvantra account
Ellen AB (publ) (ELN.ST)
Key financial summary
Financials in SEK| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | SEK m | 21 | 19 | 19 | 24 | 26 | 23 | 22 |
| Operating profit | SEK m | -1 | -5 | |||||
| Net profit | SEK m | -7 | -8 | -6 | -5 | -3 | -1 | -2 |
| EPS reported | SEK | -0.11 | -0.18 | |||||
| Operating cashflow per share | SEK | 0.12 | 0.12 | |||||
| Capex per share | SEK | 0.00 | 0.00 | |||||
| FCF per share | SEK | 0.12 | 0.12 | |||||
| Free cash flow | SEK m | 1 | -3 | |||||
| Net debt | SEK m | -2 | -1 | |||||
| Book value equity | SEK m | 5 | 4 | |||||
| Book value per share | SEK | 0.41 | 0.32 | |||||
| Number of shares | m | 11.08 | 11.08 | |||||
| DPS (TTM paid) | SEK | 0.00 | 0.00 |
Financial summary
Financials in SEK| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 2.44 | 3.96 | |||||
| P/S LTM | x | 0.49 | 0.65 | |||||
| P/FCF LTM | x | 8.17 | -5.39 | |||||
| EV/EBITDA LTM | x | -6.95 | -7.00 | |||||
| EV/Sales LTM | x | 0.38 | 0.62 | |||||
| Earnings Yield LTM | % | -11.21% | -8.76% | |||||
| FCF Yield | % | 12.24% | -18.55% | |||||
| Quality | ||||||||
| ROE | % | -27.37% | -24.08% | |||||
| ROIC | % | -27.68% | -27.68% | |||||
| Operating margin | % | -5.56% | -5.56% | |||||
| Gross margin | % | 47.57% | 47.57% | |||||
| FCF/Sales | % | 6.00% | 6.00% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -11.69% | -16.01% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | - | - | |||||
| Net Debt/EBITDA | x | 1.95 | 1.95 | |||||
| EBIT/Net interest | x | 0.00 | 0.00 | |||||
| Net debt/market cap | % | -21.90% | -3.55% | |||||
| Net debt/Equity | x | -0.53 | -0.14 | |||||
| Gross debt/equity | x | 0.00 | 0.00 | |||||
Company overview
Ellen AB (publ) is a Swedish biotechnology firm specializing in the development and marketing of self-care products for women's intimate health. Its diverse product portfolio includes the ellen Probiotic Tampon, which combines sanitary protection with the delivery of beneficial lactic acid bacteria to support vaginal flora. Another key offering is the ellen Probiotic Intimate Crème, a hydrating cream designed to act as a protective barrier for delicate intimate skin and mucous membranes. For personal health monitoring, the company provides ellen pH-Control, a medical device enabling convenient at-home measurement of vaginal pH levels. Additionally, Ellen AB offers the ellen Sport Tampong/Aqua Block, engineered to prevent chlorinated or contaminated water from entering the vagina during swimming and other water-based activities. Under the LN brand, the company also presents a range of intimate hygiene solutions: LN Intimate Cleansing Foam, which cleanses and doubles as a shaving cream for intimate grooming; LN Intimate Deo, a softening deodorant formulated with lactic acid to foster a healthy vaginal environment; and LN After Shave & Wax Gel, developed to soothe skin after hair removal in intimate or other body areas. Ellen AB's products are distributed across several European markets, including France, Belgium, Germany, Switzerland, Austria, and Scandinavia. The company utilizes a network of distributors and retailers for sales, complemented by online sales specifically targeting the Scandinavian region. Founded in 2000, Ellen AB (publ) is headquartered in Stockholm, Sweden.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Ellen AB (publ) (ELN.ST)
Ellen AB (publ) is a Swedish biotechnology firm specializing in the development and marketing of self-care products for women's intimate health. Its diverse product portfolio includes the ellen Probiotic Tampon, which combines sanitary protection with the delivery of beneficial lactic acid bacteria to support vaginal flora. Another key offering is the ellen Probiotic Intimate Crème, a hydrating cream designed to act as a protective barrier for delicate intimate skin and mucous membranes. For personal health monitoring, the company provides ellen pH-Control, a medical device enabling convenient at-home measurement of vaginal pH levels. Additionally, Ellen AB offers the ellen Sport Tampong/Aqua Block, engineered to prevent chlorinated or contaminated water from entering the vagina during swimming and other water-based activities. Under the LN brand, the company also presents a range of intimate hygiene solutions: LN Intimate Cleansing Foam, which cleanses and doubles as a shaving cream for intimate grooming; LN Intimate Deo, a softening deodorant formulated with lactic acid to foster a healthy vaginal environment; and LN After Shave & Wax Gel, developed to soothe skin after hair removal in intimate or other body areas. Ellen AB's products are distributed across several European markets, including France, Belgium, Germany, Switzerland, Austria, and Scandinavia. The company utilizes a network of distributors and retailers for sales, complemented by online sales specifically targeting the Scandinavian region. Founded in 2000, Ellen AB (publ) is headquartered in Stockholm, Sweden.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free